{"id":"https://openalex.org/W4406056591","doi":"https://doi.org/10.1016/s0022-3565(24)35000-1","title":"Z-350, A Novel Compound with \u03b11-Adrenoceptor Antagonistic and Steroid 5\u03b1-Reductase Inhibitory Actions: Pharmacological Properties In Vivo","display_name":"Z-350, A Novel Compound with \u03b11-Adrenoceptor Antagonistic and Steroid 5\u03b1-Reductase Inhibitory Actions: Pharmacological Properties In Vivo","publication_year":1999,"publication_date":"1999-09-01","ids":{"openalex":"https://openalex.org/W4406056591","doi":"https://doi.org/10.1016/s0022-3565(24)35000-1","mag":"1962511894","pmid":"https://pubmed.ncbi.nlm.nih.gov/10454472"},"language":"en","primary_location":{"id":"doi:10.1016/s0022-3565(24)35000-1","doi":"https://doi.org/10.1016/s0022-3565(24)35000-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)35000-1","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113923000","display_name":"Yoshihisa Fukuta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126322","display_name":"Zeria Pharmaceutical (Japan)","ror":"https://ror.org/02j4jqr44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210126322"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshihisa Fukuta","raw_affiliation_strings":["Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I4210126322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110723911","display_name":"Youichi Fukuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126322","display_name":"Zeria Pharmaceutical (Japan)","ror":"https://ror.org/02j4jqr44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210126322"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Youichi Fukuda","raw_affiliation_strings":["Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I4210126322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049691925","display_name":"Raita Higashino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126322","display_name":"Zeria Pharmaceutical (Japan)","ror":"https://ror.org/02j4jqr44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210126322"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Raita Higashino","raw_affiliation_strings":["Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I4210126322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101685685","display_name":"Kenji Yoshida","orcid":"https://orcid.org/0009-0003-4186-0437","observed_orcids":["https://orcid.org/0009-0003-4186-0437"]},"institutions":[{"id":"https://openalex.org/I4210126322","display_name":"Zeria Pharmaceutical (Japan)","ror":"https://ror.org/02j4jqr44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210126322"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Yoshida","raw_affiliation_strings":["Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I4210126322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112791704","display_name":"Masayuki Ogishima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126322","display_name":"Zeria Pharmaceutical (Japan)","ror":"https://ror.org/02j4jqr44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210126322"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki Ogishima","raw_affiliation_strings":["Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I4210126322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101465837","display_name":"Hajime Tamaki","orcid":"https://orcid.org/0000-0003-1533-1657","observed_orcids":["https://orcid.org/0000-0003-1533-1657"]},"institutions":[{"id":"https://openalex.org/I4210126322","display_name":"Zeria Pharmaceutical (Japan)","ror":"https://ror.org/02j4jqr44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210126322"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hajime Tamaki","raw_affiliation_strings":["Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I4210126322"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103709381","display_name":"Mineo Takei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126322","display_name":"Zeria Pharmaceutical (Japan)","ror":"https://ror.org/02j4jqr44","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210126322"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mineo Takei","raw_affiliation_strings":["Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Zeria Pharmaceutical Co. Ltd., Saitama, Japan","institution_ids":["https://openalex.org/I4210126322"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5113923000"],"corresponding_institution_ids":["https://openalex.org/I4210126322"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":1.3556,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.7836408,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"290","issue":"3","first_page":"1013","last_page":"1018"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha1-adrenoceptor-antagonism","display_name":"alpha1-adrenoceptor antagonism","score":0.8510000109672546},{"id":"https://openalex.org/keywords/5alpha-reductase-inhibition","display_name":"5\u03b1-reductase inhibition","score":0.9129999876022339},{"id":"https://openalex.org/keywords/benign-prostatic-hyperplasia","display_name":"benign prostatic hyperplasia","score":0.8999999761581421},{"id":"https://openalex.org/keywords/dihydrotestosterone","display_name":"dihydrotestosterone","score":0.953000009059906},{"id":"https://openalex.org/keywords/bladder-outlet-obstruction","display_name":"bladder outlet obstruction","score":0.9089999794960022},{"id":"https://openalex.org/keywords/orthostatic-hypotension","display_name":"orthostatic hypotension","score":0.8270000219345093},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6069999933242798},{"id":"https://openalex.org/keywords/tamsulosin","display_name":"tamsulosin","score":0.7730000019073486},{"id":"https://openalex.org/keywords/prazosin","display_name":"prazosin","score":0.925000011920929},{"id":"https://openalex.org/keywords/piperazine-derivatives","display_name":"piperazine derivatives","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7889919877052307},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.6804355978965759},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6169252395629883},{"id":"https://openalex.org/C2780902042","wikidata":"https://www.wikidata.org/wiki/Q177911","display_name":"Steroid","level":3,"score":0.5810298323631287},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46490561962127686},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31846320629119873},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.26266783475875854},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18048113584518433},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.04515978693962097},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004386","descriptor_name":"Duodenum","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006133","descriptor_name":"Growth Substances","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007024","descriptor_name":"Hypotension, Orthostatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009929","descriptor_name":"Organ Size","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010656","descriptor_name":"Phenylephrine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011467","descriptor_name":"Prostate","qualifier_ui":"Q000033","qualifier_name":"anatomy & histology","is_major_topic":false},{"descriptor_ui":"D011467","descriptor_name":"Prostate","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D011470","descriptor_name":"Prostatic Hyperplasia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013196","descriptor_name":"Dihydrotestosterone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013739","descriptor_name":"Testosterone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014521","descriptor_name":"Urethra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014521","descriptor_name":"Urethra","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058891","descriptor_name":"5-alpha Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/s0022-3565(24)35000-1","doi":"https://doi.org/10.1016/s0022-3565(24)35000-1","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)35000-1","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:10454472","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10454472","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.927.3707","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.927.3707","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jpet.aspetjournals.org/content/290/3/1013.full.pdf","raw_type":"text"},{"id":"mag:1962511894","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10454472","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W101374796","https://openalex.org/W107210901","https://openalex.org/W109614840","https://openalex.org/W1870803056","https://openalex.org/W1880422146","https://openalex.org/W1963970177","https://openalex.org/W1972105537","https://openalex.org/W1978253417","https://openalex.org/W1992103956","https://openalex.org/W1998724133","https://openalex.org/W2000173210","https://openalex.org/W2000643141","https://openalex.org/W2017436626","https://openalex.org/W2017626297","https://openalex.org/W2017990149","https://openalex.org/W2027586930","https://openalex.org/W2030430042","https://openalex.org/W2041937565","https://openalex.org/W2050845481","https://openalex.org/W2064256677","https://openalex.org/W2065323621","https://openalex.org/W2066572223","https://openalex.org/W2067746505","https://openalex.org/W2080492299","https://openalex.org/W2084886742","https://openalex.org/W2085293854","https://openalex.org/W2086144348","https://openalex.org/W2102278308","https://openalex.org/W2105279687","https://openalex.org/W2128981596","https://openalex.org/W2134005946","https://openalex.org/W2135389629","https://openalex.org/W2244779068","https://openalex.org/W2258115004","https://openalex.org/W2331302678","https://openalex.org/W2404555905","https://openalex.org/W2410150720","https://openalex.org/W2465227245","https://openalex.org/W2804551733","https://openalex.org/W3141076278","https://openalex.org/W4256004280","https://openalex.org/W4406382317"],"related_works":["https://openalex.org/W1962511894","https://openalex.org/W7098715016","https://openalex.org/W2017626297","https://openalex.org/W2054084869","https://openalex.org/W3104556090","https://openalex.org/W4241283029","https://openalex.org/W3099339153","https://openalex.org/W2036322133","https://openalex.org/W2991502159","https://openalex.org/W2315077356"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2025-01-04T00:00:00"}